Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown125%
withdrawn125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

The Influence of Ventilation on Perioperative Neurocognitive Disorders

NCT04106869
completednot_applicable

Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients

NCT02706431
completednot_applicable

Effect of Sodium Nitroprusside on Cerebral Blood Flow

NCT03317652
unknownphase_4

Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression

NCT02924090

Clinical Trials (4)

Showing 4 of 4 trials
NCT04106869Not Applicable

The Influence of Ventilation on Perioperative Neurocognitive Disorders

Withdrawn
NCT02706431Not Applicable

Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients

Completed
NCT03317652Not Applicable

Effect of Sodium Nitroprusside on Cerebral Blood Flow

Completed
NCT02924090Phase 4

Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4